BFWA
DVAX

Benchmark Financial Wealth Advisors’s Dynavax Technologies DVAX Stock Holding History

Benchmark Financial Wealth Advisors’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,000
Closed -$89K – 64
2020
Q2 		$89K Buy
+10,000
New +$50.5K 0.07% 54

Other funds holding DVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Benchmark Financial Wealth Advisors's DVAX Position: Q3 2020 in Review

Benchmark Financial Wealth Advisors sold out of Dynavax Technologies (DVAX) in Q3 2020, closing a stake of 10,000 shares — an estimated $89K sold.

Benchmark Financial Wealth Advisors first reported a position in DVAX in Q2 2020 and held it in 1 quarter. The position peaked at $89K in Q2 2020. 165 funds tracked by Wall St. Rank hold DVAX as of Q3 2020.

  • Benchmark Financial Wealth Advisors reported no remaining Dynavax Technologies position as of Q3 2020 after selling out during the quarter.
  • Benchmark Financial Wealth Advisors sold 10,000 Dynavax Technologies shares in Q3 2020, an estimated $89K.
  • Benchmark Financial Wealth Advisors first reported a position in Dynavax Technologies in Q2 2020 and held it in 1 quarter.
  • Benchmark Financial Wealth Advisors's Dynavax Technologies position peaked at $89K in Q2 2020.
  • 165 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2020.

Based on Benchmark Financial Wealth Advisors's 13F filing for Q3 2020, filed 15 Oct 2020.